Detalhe da pesquisa
1.
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT).
Health Technol Assess
; 19(83): vii-xxiii, 1-93, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26490434
2.
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study.
Trials
; 15: 122, 2014 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726032